About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems and products primarily for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward-looking statements. Examples of these forward-looking
statements include statements as to the anticipated benefits of the credit
facility and expectations as to future growth in NxStage's business. All
forward-looking statements involve risks, uncertainties and contingencies,
many of which are beyond NxStage's control, which may cause actual results,
performance, or achievements to differ materially from anticipated results,
performance or achievements, including market acceptance and demand for
NxStage's products, growth in home and/or daily hemodialysis, and certain
other factors that may affect future operating results and which are
detailed in NxStage's filings with the Securities and Exchange Commission,
including the Annual Report on Form 10-K for the year ended December 31,
2006, the Quarterly Report on Form 10-Q for the quarter ended September 30,
2007 a
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2007 PR Newswire. All rights reserved |